Connect with us

Hi, what are you looking for?

Monday, May 16, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

EBITDA profitability a ‘transformational milestone’ for TerrAscend

TerrAscend’s strategy of focusing on US markets continue to pay off

TerrAscend

A boost to net sales has pushed cross-border operator TerrAscend, Corp. (CSE: TER) into profitable territory.

On Thursday, the company released its earnings for the quarter ending March 31.

In a statement, CEO Jason Ackerman called TerrAscend’s shift into adjusted earnings before interest, taxes, depreciation and amortization profitability “a transformational milestone.”

Stock in the business rose 6 per cent to $2.99 on the Canadian Securities Exchange Thursday.

The company reported an adjusted EBITDA of 4.9 million, up from a loss of negative $5.7 in the previous quarter.

Net sales increased 34 per cent for the quarter to $34.8 million, from $25.9 million in the previous sequential fiscal period.

In its last quarterly report, TerrAscend laid plain its strategy to focus on more profitable U.S. markets, and that strategy looks to be paying off.

Read more: Hedging bets on US market paying off for TerrAscend

Net sales in the U.S were $30.9 million for the quarter, contributing 89 per cent of total consolidated net sales.  The increase was driven by the operational scale-up of TerrAscend’s stateside footprint, notably by tripling its cultivation capacity and adding two Apothecarium dispensaries in Pennsylvania.

The company ended the quarter with $31.4 million in cash and cash equivalents, up from $11.9 in the previous quarter.

Earlier in the year, Ackerman characterized his company as Canopy Growth, Corp.‘s (TSX: WEED) betting horse in the U.S. sector after receiving hefty capital injections from the titan operator.

Read more: Canopy Growth lends TerrAscend $80.5 million

Based on the success of operations to-date, TerrAscend says it anticipates second-quarter 2020 net sales of approximately $45 million, representing 30 per cent quarter-over-quarter growth. It also predicts ongoing expansion of gross margin and adjusted EBITDA margin.

Now-permanent CEO Ackerman says U.S. operations continue to perform ahead of plan.

“With our Pennsylvania expansion complete and construction of our New Jersey facilities well underway, we’re confident in the ongoing growth targets that we have set,” he said in the statement. “We remain focused on prudently investing our capital in the markets where we see the greatest and most profitable opportunities.”

Top image via Deposit Photos

 

nick@mugglehead.com

@nick_laba

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe